HR Execs on the Move

LA CLINICA DE FAMILIA

www.lcdfnm.org

 
LA CLINICA DE FAMILIA is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.lcdfnm.org
  • 385 Calle De Alegra Ste B
    Las Cruces, NM USA 88005
  • Phone: 505.526.1105

Executives

Name Title Contact Details

Similar Companies

Gowan Health Consultants

Gowan Health Consultants is a Wallacetown, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Health Integrated

Health Integrated leads the industry with Precision Empowered Care Management, enabling health plans to precisely manage their most vulnerable members. By combining actionable big data with a proven biopsychosocial model, we address the physical, psychological and social drivers impacting member health and satisfaction. As a result, plans enhance quality, achieve compliance and strengthen their financial performance, while empowering members to achieve better outcomes.

Balboa Park

Balboa Park is a San Diego must-see, just minutes from downtown. The Park is home to 15 major museums, several performing arts venues, lovely gardens and many other cultural and recreational attractions–including the San Diego Zoo. Step into the beauty...

Master Train Inc

Master Train Inc is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Fibrocell Science

Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.